Inhaled prostacyclin for Eisenmenger syndrome complicated with miliary tuberculosis

Eva M. Marwali (Division of Cardiac Critical Care Medicine, Department of Child Health, National Cardiovascular Center, Harapan Kita Hospital, Jakarta)
Novik Budiwardhana (Division of Cardiac Critical Care Medicine, Department of Child Health, National Cardiovascular Center, Harapan Kita Hospital, Jakarta)
Anna U. Rahayoe (Division of Pediatric Cardiology, Department of Cardiology, National Cardiovascular Center, Harapan Kita Hospital, Jakarta, Indonesia.2)

Paediatrica Indonesiana
Vol 51 No 4 (2011): July 2011

Eisenmenger syndrome occurs in patients with large congenital cardiac or extracardiac left-to-right shunts. Clinically, Eisenmenger syndrome is characterized by multiple organ involvement and progressive deterioration of function over time. In the advanced stages, signs and symptoms of Eisenmenger syndrome include central cyanosis, dyspnea, fatigue, hemoptysis, syncope and right-sided heart failure. Survival of patients with Eisenmenger syndrome is generally poor, but appears to be better than that of patients with idiopathic pulmonary arterial hypertension (PAH) in a comparable functional class.1